319 related articles for article (PubMed ID: 27296897)
1. Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs.
Fabris F; Yue Y; Qu Y; Chahine M; Sobie E; Lee P; Wieczorek R; Jiang XC; Capecchi PL; Laghi-Pasini F; Lazzerini PE; Boutjdir M
J Physiol; 2016 Nov; 594(21):6175-6187. PubMed ID: 27296897
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of the Novel Autoimmune-Associated Long-QT Syndrome.
Yue Y; Castrichini M; Srivastava U; Fabris F; Shah K; Li Z; Qu Y; El-Sherif N; Zhou Z; January C; Hussain MM; Jiang XC; Sobie EA; Wahren-Herlenius M; Chahine M; Capecchi PL; Laghi-Pasini F; Lazzerini PE; Boutjdir M
Circulation; 2015 Jul; 132(4):230-40. PubMed ID: 25995318
[TBL] [Abstract][Full Text] [Related]
3. Arrhythmogenicity of Anti-Ro/SSA Antibodies in Patients With Torsades de Pointes.
Lazzerini PE; Yue Y; Srivastava U; Fabris F; Capecchi PL; Bertolozzi I; Bacarelli MR; Morozzi G; Acampa M; Natale M; El-Sherif N; Galeazzi M; Laghi-Pasini F; Boutjdir M
Circ Arrhythm Electrophysiol; 2016 Apr; 9(4):e003419. PubMed ID: 27030700
[TBL] [Abstract][Full Text] [Related]
4. BeKm-1, a peptide inhibitor of human ether-a-go-go-related gene potassium currents, prolongs QTc intervals in isolated rabbit heart.
Qu Y; Fang M; Gao B; Chui RW; Vargas HM
J Pharmacol Exp Ther; 2011 Apr; 337(1):2-8. PubMed ID: 21205913
[TBL] [Abstract][Full Text] [Related]
5. Potassium Channel Block and Novel Autoimmune-Associated Long QT Syndrome.
Boutjdir M; Lazzerini PE; Capecchi PL; Laghi-Pasini F; El-Sherif N
Card Electrophysiol Clin; 2016 Jun; 8(2):373-84. PubMed ID: 27261828
[TBL] [Abstract][Full Text] [Related]
6. Risk of QTc Interval Prolongation Associated With Circulating Anti-Ro/SSA Antibodies Among US Veterans: An Observational Cohort Study.
Lazzerini PE; Cevenini G; Qu YS; Fabris F; El-Sherif N; Acampa M; Cartocci A; Laghi-Pasini F; Capecchi PL; Boutjdir M; Lazaro D
J Am Heart Assoc; 2021 Feb; 10(4):e018735. PubMed ID: 33533258
[TBL] [Abstract][Full Text] [Related]
7. SKF-96365 blocks human ether-à-go-go-related gene potassium channels stably expressed in HEK 293 cells.
Liu H; Yang L; Chen KH; Sun HY; Jin MW; Xiao GS; Wang Y; Li GR
Pharmacol Res; 2016 Feb; 104():61-9. PubMed ID: 26689773
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of gefitinib-induced QT prolongation.
Jie LJ; Li YD; Zhang HQ; Mao L; Xie HB; Zhou FG; Zhou TL; Xie D; Lin JL; Li GY; Cai BN; Zhang YH; Wang Y
Eur J Pharmacol; 2021 Nov; 910():174441. PubMed ID: 34474028
[TBL] [Abstract][Full Text] [Related]
9. Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases.
Lazzerini PE; Acampa M; Guideri F; Capecchi PL; Campanella V; Morozzi G; Galeazzi M; Marcolongo R; Laghi-Pasini F
Arthritis Rheum; 2004 Apr; 50(4):1248-52. PubMed ID: 15077308
[TBL] [Abstract][Full Text] [Related]
10. In vivo effects of the IKr agonist NS3623 on cardiac electrophysiology of the guinea pig.
Hansen RS; Olesen SP; Rønn LC; Grunnet M
J Cardiovasc Pharmacol; 2008 Jul; 52(1):35-41. PubMed ID: 18594476
[TBL] [Abstract][Full Text] [Related]
11. Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity.
Lazzerini PE; Capecchi PL; Acampa M; Morozzi G; Bellisai F; Bacarelli MR; Dragoni S; Fineschi I; Simpatico A; Galeazzi M; Laghi-Pasini F
Arthritis Care Res (Hoboken); 2011 Oct; 63(10):1463-70. PubMed ID: 21739618
[TBL] [Abstract][Full Text] [Related]
12. Anti-Ro/SSA Antibodies and the Autoimmune Long-QT Syndrome.
Lazzerini PE; Laghi-Pasini F; Boutjdir M; Capecchi PL
Front Med (Lausanne); 2021; 8():730161. PubMed ID: 34552948
[TBL] [Abstract][Full Text] [Related]
13. Anti-Ro52 antibody acts on the S5-pore linker of hERG to chronically reduce channel expression.
Szendrey J; Lamothe SM; Vanner S; Guo J; Yang T; Li W; Davis J; Joneja M; Baranchuk A; Zhang S
Cardiovasc Res; 2019 Aug; 115(10):1500-1511. PubMed ID: 30544220
[TBL] [Abstract][Full Text] [Related]
14. Oxycodone is associated with dose-dependent QTc prolongation in patients and low-affinity inhibiting of hERG activity in vitro.
Fanoe S; Jensen GB; Sjøgren P; Korsgaard MP; Grunnet M
Br J Clin Pharmacol; 2009 Feb; 67(2):172-9. PubMed ID: 19159406
[TBL] [Abstract][Full Text] [Related]
15. The anesthetized guinea pig: an effective early cardiovascular derisking and lead optimization model.
Morissette P; Nishida M; Trepakova E; Imredy J; Lagrutta A; Chaves A; Hoagland K; Hoe CM; Zrada MM; Travis JJ; Zingaro GJ; Gerenser P; Friedrichs G; Salata JJ
J Pharmacol Toxicol Methods; 2013; 68(1):137-49. PubMed ID: 23649000
[TBL] [Abstract][Full Text] [Related]
16. Galantamine (Reminyl) delays cardiac ventricular repolarization and prolongs the QT interval by blocking the HERG current.
Vigneault P; Bourgault S; Kaddar N; Caillier B; Pilote S; Patoine D; Simard C; Drolet B
Eur J Pharmacol; 2012 Apr; 681(1-3):68-74. PubMed ID: 22366430
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a crucial modulating role of the sodium channel in the QTc prolongation related to antipsychotics.
Silvestre JS; O'Neill MF; Prous JR
J Psychopharmacol; 2014 Apr; 28(4):329-40. PubMed ID: 24327451
[TBL] [Abstract][Full Text] [Related]
18. Restoring depressed HERG K+ channel function as a mechanism for insulin treatment of abnormal QT prolongation and associated arrhythmias in diabetic rabbits.
Zhang Y; Xiao J; Wang H; Luo X; Wang J; Villeneuve LR; Zhang H; Bai Y; Yang B; Wang Z
Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1446-55. PubMed ID: 16617123
[TBL] [Abstract][Full Text] [Related]
19. Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease.
Lazzerini PE; Capecchi PL; Guideri F; Bellisai F; Selvi E; Acampa M; Costa A; Maggio R; Garcia-Gonzalez E; Bisogno S; Morozzi G; Galeazzi M; Laghi-Pasini F
Am J Cardiol; 2007 Sep; 100(6):1029-34. PubMed ID: 17826392
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel.
Kang J; Chen XL; Wang H; Ji J; Cheng H; Incardona J; Reynolds W; Viviani F; Tabart M; Rampe D
Mol Pharmacol; 2005 Mar; 67(3):827-36. PubMed ID: 15548764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
